Quick Summary
Additional Context
Hear from the experts shaping additive manufacturing software. Join 3D Printing Industry on 22 October for AMA: Software 2026, featuring exclusive presentations, panels and live Q&A!
Myrava, formerly known as Ricoh 3D for Healthcare, has received U.S. Food and Drug Administration 510(k) clearance for a patient-specific 3D printed bolus used in radiation therapy. The clearance adds a treatment accessory to a portfolio that has so far centered on diagnostic anatomical models. It also gives the company a regulated product for radiation oncology departments, a hospital segment where custom 3D printing has mostly been done in-house on an ad hoc basis.
A bolus is a layer of tissue-equivalent material placed directly on a patient’s skin during radiotherapy. It changes how the radiation dose is